B.PadillaK
July 20: Four years after it was rejected by the FDA due to safety concerns, Daiichi Sankyos Vanflyta (quizartinib) won approval to treat patients with acute myeloid leukemia that has a FLT3-ITD gene mutation
If you experience severe pain, signs of allergic reaction, or difficulty breathing, seek emergency medical attention
Guidance from the National Institute of Diabetes and Digestive and Kidney Diseases explains that prescription weight medications are meant to complement lifestyle changes, not replace them, and are typically reserved for specific candidates
Autoantibodies of the AChR exert their effects through three mechanisms: 1) the complement is activated by antibodies bound to the AChR, triggering a cascade reaction that forms the MAC, causing tissue destruction and inflammation
Some patients tolerate or respond better to semaglutide